Core Viewpoint - Ardent Health, Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with significant financial implications for investors who acquired securities during the specified class period [1]. Summary by Relevant Sections Class Action Lawsuit Details - Investors who purchased Ardent Health securities between July 18, 2024, and November 12, 2025, have until March 9, 2026, to seek appointment as lead plaintiff in the class action lawsuit [1]. - The lawsuit alleges that Ardent Health and its executives made false or misleading statements regarding the company's financial practices and accounts receivable [1]. Allegations Against Ardent Health - The lawsuit claims that Ardent Health did not rely on detailed reviews of historical collections for determining the collectability of accounts receivable [1]. - It is alleged that the company utilized a 180-day cliff for accounts receivable, allowing it to report inflated amounts and delay loss recognition [1]. - The financial position reported by Ardent Health is claimed to be materially false and misleading due to insufficient professional malpractice liability insurance and reserves [1]. Financial Impact - On November 12, 2025, Ardent Health reported a $43 million decrease in third-quarter 2025 revenue, attributed to revised accounts receivable collectability determinations [1]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing persistent industry-wide cost pressures [1]. - Additionally, a $54 million increase in professional liability reserves was recorded due to recent settlements and ongoing litigation, influenced by broader industry trends [1]. - Following these announcements, Ardent Health's stock price fell nearly 34% [1].
MONDAY DEADLINE: Ardent Health, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law